Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation. / Rittig, Anne H.; Johansen, Claus; Celis, Pamela; Odum, Niels; Litman, Thomas; Woetmann, Anders; Lindahl, Lise M.; Iversen, Lars.

In: Experimental Dermatology, Vol. 30, No. 8, 2021, p. 1141-1149.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rittig, AH, Johansen, C, Celis, P, Odum, N, Litman, T, Woetmann, A, Lindahl, LM & Iversen, L 2021, 'Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation', Experimental Dermatology, vol. 30, no. 8, pp. 1141-1149. https://doi.org/10.1111/exd.14124

APA

Rittig, A. H., Johansen, C., Celis, P., Odum, N., Litman, T., Woetmann, A., Lindahl, L. M., & Iversen, L. (2021). Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation. Experimental Dermatology, 30(8), 1141-1149. https://doi.org/10.1111/exd.14124

Vancouver

Rittig AH, Johansen C, Celis P, Odum N, Litman T, Woetmann A et al. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation. Experimental Dermatology. 2021;30(8):1141-1149. https://doi.org/10.1111/exd.14124

Author

Rittig, Anne H. ; Johansen, Claus ; Celis, Pamela ; Odum, Niels ; Litman, Thomas ; Woetmann, Anders ; Lindahl, Lise M. ; Iversen, Lars. / Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation. In: Experimental Dermatology. 2021 ; Vol. 30, No. 8. pp. 1141-1149.

Bibtex

@article{52ec341c2e404c73befab67ea1c23187,
title = "Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation",
abstract = "Background: Several cancers, including mycosis fungoides (MF), have reported dysregulation of miR-195-5p. miR-195-5p plays a role in cell cycle regulation in several malignant diseases. Objectives: This study aimed to investigate: (a) the expression level of miR-195-5p in lesional MF skin biopsies and (b) the potential regulatory roles of miR-195-5p in MF. Methods: Quantitative real-time polymerase chain reaction (RT-qPCR) was used to determine miR-195-5p expression in MF skin biopsies and cell lines. The effect of miR-195-5p and ADP-ribosylation factor-like protein 2 (ARL2) on cell cycle and apoptosis was measured by flow cytometry assays. Changes in ARL2 expression were determined by RT-qPCR and Western blotting (WB). Results: We found lower expression levels of miR-195-5p in lesional skin from MF patients compared with non-lesional MF skin and skin from healthy volunteers. Additionally, miR-195-5p showed lower expression levels in the skin from patients with disease progression compared with patients with stable disease. In vitro studies showed that overexpression of miR-195-5p induced a cell cycle arrest in G0G1. Using microarray analysis, we identified several genes that were regulated after miR-195-5p overexpression. The most downregulated gene after miR-195-5p mimic transfection was ARL2. RT-qPCR and WB analyses confirmed downregulation of ARL2 following transfection with miR-195-5p mimic. Lastly, transfection with siRNA against ARL2 also induced a G0G1 arrest. Conclusion: Upregulation of miR-195-5p in MF inhibits cycle arrest by downregulation of ARL2. miR-195-5p may thus function as a tumor suppressor in MF and low miR-195-5p expression in lesional MF skin may promote disease progression.",
keywords = "ARL2, cancer, cell cycle arrest, cutaneous T-cell lymphoma, microarray, microRNA, proliferation, tumor suppressor",
author = "Rittig, {Anne H.} and Claus Johansen and Pamela Celis and Niels Odum and Thomas Litman and Anders Woetmann and Lindahl, {Lise M.} and Lars Iversen",
year = "2021",
doi = "10.1111/exd.14124",
language = "English",
volume = "30",
pages = "1141--1149",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation

AU - Rittig, Anne H.

AU - Johansen, Claus

AU - Celis, Pamela

AU - Odum, Niels

AU - Litman, Thomas

AU - Woetmann, Anders

AU - Lindahl, Lise M.

AU - Iversen, Lars

PY - 2021

Y1 - 2021

N2 - Background: Several cancers, including mycosis fungoides (MF), have reported dysregulation of miR-195-5p. miR-195-5p plays a role in cell cycle regulation in several malignant diseases. Objectives: This study aimed to investigate: (a) the expression level of miR-195-5p in lesional MF skin biopsies and (b) the potential regulatory roles of miR-195-5p in MF. Methods: Quantitative real-time polymerase chain reaction (RT-qPCR) was used to determine miR-195-5p expression in MF skin biopsies and cell lines. The effect of miR-195-5p and ADP-ribosylation factor-like protein 2 (ARL2) on cell cycle and apoptosis was measured by flow cytometry assays. Changes in ARL2 expression were determined by RT-qPCR and Western blotting (WB). Results: We found lower expression levels of miR-195-5p in lesional skin from MF patients compared with non-lesional MF skin and skin from healthy volunteers. Additionally, miR-195-5p showed lower expression levels in the skin from patients with disease progression compared with patients with stable disease. In vitro studies showed that overexpression of miR-195-5p induced a cell cycle arrest in G0G1. Using microarray analysis, we identified several genes that were regulated after miR-195-5p overexpression. The most downregulated gene after miR-195-5p mimic transfection was ARL2. RT-qPCR and WB analyses confirmed downregulation of ARL2 following transfection with miR-195-5p mimic. Lastly, transfection with siRNA against ARL2 also induced a G0G1 arrest. Conclusion: Upregulation of miR-195-5p in MF inhibits cycle arrest by downregulation of ARL2. miR-195-5p may thus function as a tumor suppressor in MF and low miR-195-5p expression in lesional MF skin may promote disease progression.

AB - Background: Several cancers, including mycosis fungoides (MF), have reported dysregulation of miR-195-5p. miR-195-5p plays a role in cell cycle regulation in several malignant diseases. Objectives: This study aimed to investigate: (a) the expression level of miR-195-5p in lesional MF skin biopsies and (b) the potential regulatory roles of miR-195-5p in MF. Methods: Quantitative real-time polymerase chain reaction (RT-qPCR) was used to determine miR-195-5p expression in MF skin biopsies and cell lines. The effect of miR-195-5p and ADP-ribosylation factor-like protein 2 (ARL2) on cell cycle and apoptosis was measured by flow cytometry assays. Changes in ARL2 expression were determined by RT-qPCR and Western blotting (WB). Results: We found lower expression levels of miR-195-5p in lesional skin from MF patients compared with non-lesional MF skin and skin from healthy volunteers. Additionally, miR-195-5p showed lower expression levels in the skin from patients with disease progression compared with patients with stable disease. In vitro studies showed that overexpression of miR-195-5p induced a cell cycle arrest in G0G1. Using microarray analysis, we identified several genes that were regulated after miR-195-5p overexpression. The most downregulated gene after miR-195-5p mimic transfection was ARL2. RT-qPCR and WB analyses confirmed downregulation of ARL2 following transfection with miR-195-5p mimic. Lastly, transfection with siRNA against ARL2 also induced a G0G1 arrest. Conclusion: Upregulation of miR-195-5p in MF inhibits cycle arrest by downregulation of ARL2. miR-195-5p may thus function as a tumor suppressor in MF and low miR-195-5p expression in lesional MF skin may promote disease progression.

KW - ARL2

KW - cancer

KW - cell cycle arrest

KW - cutaneous T-cell lymphoma

KW - microarray

KW - microRNA

KW - proliferation

KW - tumor suppressor

U2 - 10.1111/exd.14124

DO - 10.1111/exd.14124

M3 - Journal article

C2 - 32492224

AN - SCOPUS:85087170444

VL - 30

SP - 1141

EP - 1149

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 8

ER -

ID: 244612350